Lupus Nephritis in Northeastern India: Navigating the complex landscape of clinical challenges and emerging healthcare opportunities
Article Sidebar
Downloads
Submit your own article
Register as an author to reserve your spot in the next issue of the Medical Research Archives.
Author RegistrationJoin the Society
The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.
Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.
MembershipMain Article Content
Abstract
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with varied manifestations, significantly impacting women and potentially leading to Lupus Nephritis (LN), a major cause of morbidity and mortality. The review article explores the unique challenges and opportunities in managing lupus nephritis (LN) in North Eastern India, a region characterised by diverse ethnicities, cultures, and socioeconomic challenges. With a higher than average prevalence of systemic lupus erythematosus (SLE) and lupus nephritis (LN), the region presents distinct epidemiological patterns, likely influenced by genetic, environmental, and lifestyle factors. The management and prognosis of LN are further complicated by the region's geographical and infrastructural limitations, including access to specialised healthcare and socioeconomic barriers, which impacts the patient’s outcome. Despite the challenges, there are emerging opportunities for improvement through innovations in healthcare delivery, governmental and non-governmental initiatives aimed at enhancing healthcare access, and the adaptation of treatment guidelines to the local context. This review article underscores the importance of region-specific research and healthcare strategies to improve care and outcome for lupus nephritis (LN) patients in North Eastern India, thus contributing to the broader understanding of the disease in diverse populations and settings.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Bastian HM, Roseman JM, Mcgwin G, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 2002;11(3):152-160. doi:https://doi.org/10.1191/0961203302lu158oa
3. Hanly JG, O’Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 2016;55:252–62.
4. Mahajan A, Amelio J, Gairy K, et al. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus. 2020;29(9):1011-1020. doi:https://doi.org/10.1177/0961203320932219
5. Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A. Prevalence of Systemic Lupus Erythematosus in India. Lupus. 1993;2(2):115-118. doi:https://doi.org/10.1177/0961 20339300200209
6. Seligman VA, Lum RF, Olson JL, Li H, Criswell LA. Demographic differences in the development of lupus nephritis: a retrospective analysis. The American Journal of Medicine. 2002;112(9):726-729. doi:https://doi.org/10.1016/S0002-9343(02)01118-X
7. Das J, Kalita P, Dey B, et al. Clinicopathological, Immunological, and Laboratory Parameters of Childhood Lupus Nephritis: A Study from Northeast India. Journal of laboratory physicians. 2023;15(03):361-364. doi:https://doi.org/10.1055/s-0043-1768168
8. Sharma M, Das H, Doley P, Mahanta P. Clinical and histopathological profile of lupus nephritis and response to treatment with cyclophosphamide: A single center study. Saudi Journal of Kidney Diseases and Transplantation. 2019;30(2):501. doi:https://doi.org/ 10.4103/1319-2442.256857
9. Hocaoglu M, Valenzuela‐Almada MO, Dabit JY, et al. Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population‐Based Study Over Four Decades—The Lupus Midwest Network ( LUMEN ). Arthritis & Rheumatology. Published online October 13, 2022. doi:https://doi.org/10.1002/art.42375
10. Bhattacharya PK, Barman AK, Shinde SA. A clinical study of lupus nephritis in a tertiary care hospital in northeast India. Indian Journal of Medical Specialities. 2015;6(4):136-140. doi:https://doi.org/10.1016/j.injms.2015.07.005
11. Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology. 2013;52(12):2108-2115. doi:https://doi.org/10.1093/rheumatology/ket160
12. Chatterjee R, Aggarwal A. Challenges in the diagnosis and management of SLE in India. Clinical Immunology Communications. 2023;4:65-69. doi:https://doi.org/10.1016/j.clicom.2023.10.001
13. Kernder, J.G. Richter, R. Fischer-Betz, B. Winkler-Rohlfing, R. Brinks, M. Aringer, et al.Lupus, 30 (3) (2021), pp. 431-438
14. Raj P, Gupta N. A Review of the National Family Health Survey Data in Addressing India’s Maternal Health Situation. Public Health Reviews. 2022;43. doi:https://doi.org/10.3389/phrs.2022.1604825
15. Wada Y, Ito S, Ueno M, Nakano M, Arakawa M, Gejyo F. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis. Nephron Clinical Practice 2004;98:c105–11.
16. Alam S, Parry M, Sharma M, Jeelani H, Mazumder M. Clinicopathological Features of Lupus Nephritis Patients in North-East India; A Single Center Retrospective Observational Study. Journal of Renal and Hepatic Disorders. 2021;6(1):1-6. doi:https://doi.org/10.15586/ jrenhep.v6i1.130
17. Pattanaik SS, Muhammed H, Chatterjee R, et al. In-hospital mortality and its predictors in a cohort of SLE from Northern India. Lupus. 2020;29(14):1971-1977. doi:https://doi.org/10.1177/0961203320961474
18. Malvar A, Pirruccio P, Alberton V, et al. Histologic versus clinical remission in proliferative lupus nephritis. Nephrology Dialysis Transplantation. 2017;32(8):1338-1344. doi:https://doi.org/10.1093/ndt/gfv296
19. Blomjous BS, Johanna I P de V, Zijlstra E, Cramer K, Voskuyl AE, Bultink and IEM. Desire to have children and preferences regarding to pre-pregnancy counselling in women with SLE. Rheumatology. 2020;60(6):2706-2713. doi:https://doi.org/10.1093/rheumatology/keaa684
20. Sharma M, Bora F, Gayatri Pegu, Prodip Kumar Doley. #3507 Iv cyclophosphamide versus mycophenolate mofetil as induction regimen in proliferative lupus nephritis: a study from north-east india. Nephrology Dialysis Transplantation. 2023;38(Supplement_1). doi:https://doi.org/10.1093/ndt/gfad063c_3507
21. Mahanta PJ, Sharma M, Alam S, Doley PK, Pegu G, Mazumder MA. P0342A Study of treatment with rituximab in refractory lupus nephritis. Nephrology Dialysis Transplantation. 2020;35 (Supplement_3). doi: https://doi.org/10.1093/ndt / gfaa 142.p0342